Ingrasciotta, Ylenia
 Distribuzione geografica
Continente #
EU - Europa 155
NA - Nord America 22
AS - Asia 21
AF - Africa 4
OC - Oceania 1
SA - Sud America 1
Totale 204
Nazione #
IT - Italia 90
IE - Irlanda 34
US - Stati Uniti d'America 22
VN - Vietnam 12
PL - Polonia 10
CZ - Repubblica Ceca 9
DZ - Algeria 4
RU - Federazione Russa 3
TR - Turchia 3
GB - Regno Unito 2
KR - Corea 2
NO - Norvegia 2
AU - Australia 1
CL - Cile 1
DE - Germania 1
HK - Hong Kong 1
ID - Indonesia 1
IN - India 1
NL - Olanda 1
RO - Romania 1
SE - Svezia 1
SG - Singapore 1
UA - Ucraina 1
Totale 204
Città #
Messina 68
Dublin 34
Dong Ket 12
Warsaw 10
Rome 9
Aflou 4
Boardman 4
Catania 4
Fleming Island 4
Ashburn 3
Fort Lauderdale 3
Brooklyn 2
Mapo-gu 2
Oslo 2
San Vito Chietino 2
Bolzano Bellunese 1
Caltagirone 1
Canberra 1
Central 1
Council Bluffs 1
Florence 1
Focsani 1
Jakarta 1
Kolkata 1
Manchester 1
Pozzo Di Gotto 1
Santiago 1
Totale 175
Nome #
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014, file de3e52b1-a6f0-762d-e053-3705fe0a30e0 41
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study, file de3e52b3-3eae-762d-e053-3705fe0a30e0 21
Analgesic drug use in elderly persons: A population-based study in Southern Italy, file de3e52b2-241f-762d-e053-3705fe0a30e0 19
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study, file de3e52af-3845-762d-e053-3705fe0a30e0 18
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study, file de3e52b0-4a39-762d-e053-3705fe0a30e0 18
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study, file de3e52b3-3ea9-762d-e053-3705fe0a30e0 14
Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction., file de3e52b3-d1f1-762d-e053-3705fe0a30e0 14
The economic burden of preventable adverse drug reactions: a systematic review of observational studies, file de3e52b3-a6a9-762d-e053-3705fe0a30e0 6
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease, file de3e52ae-edde-762d-e053-3705fe0a30e0 5
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013, file de3e52b0-502f-762d-e053-3705fe0a30e0 5
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014, file de3e52b0-5604-762d-e053-3705fe0a30e0 5
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy, file de3e52b3-0579-762d-e053-3705fe0a30e0 5
Recent advances in the management of chemotherapy-induced neutropenia: Biosimilar granulocyte colony-stimulating factor use in Italy, file de3e52b3-85b6-762d-e053-3705fe0a30e0 5
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?, file de3e52b5-7158-762d-e053-3705fe0a30e0 4
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset, file 5273dc49-cd8d-4f7c-8142-bb833d6328a3 3
Medication is an additional source of phosphate intake in chronic kidney disease patients, file de3e52b0-4766-762d-e053-3705fe0a30e0 2
null, file de3e52b1-a3a2-762d-e053-3705fe0a30e0 2
null, file de3e52b1-bf08-762d-e053-3705fe0a30e0 2
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study, file de3e52b3-1a54-762d-e053-3705fe0a30e0 2
1. Real World Evidence vs. Real World Data: definizioni e razionale, file de3e52b3-975a-762d-e053-3705fe0a30e0 2
Non-Motherhood between Obligation and Choice: Statistical Analysis Based on Permutation Tests of Spontaneous and Induced Abortion Rates in the Italian Context, file d41c091c-4752-485f-b372-d167123a6560 1
The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy, file de3e52ae-ef01-762d-e053-3705fe0a30e0 1
null, file de3e52b1-47a1-762d-e053-3705fe0a30e0 1
null, file de3e52b1-4ce0-762d-e053-3705fe0a30e0 1
null, file de3e52b1-a63b-762d-e053-3705fe0a30e0 1
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation From Italy, file de3e52b3-862f-762d-e053-3705fe0a30e0 1
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari, file de3e52b3-8635-762d-e053-3705fe0a30e0 1
Erratum: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study (BMC Nephrology (2019) 20 (359) DOI: 10.1186/s12882-019-1554-0), file de3e52b3-873b-762d-e053-3705fe0a30e0 1
Erratum: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study (BMC Nephrology (2019) 20 (359) DOI: 10.1186/s12882-019-1554-0), file de3e52b3-9aa5-762d-e053-3705fe0a30e0 1
Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies, file de3e52b4-c176-762d-e053-3705fe0a30e0 1
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy, file de3e52b4-c178-762d-e053-3705fe0a30e0 1
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease, file de3e52b5-583a-762d-e053-3705fe0a30e0 1
null, file de3e52b5-6f0f-762d-e053-3705fe0a30e0 1
Totale 206
Categoria #
all - tutte 400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 400


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 1 0 1 0 0 0 0 0
2019/20209 0 0 0 0 0 0 0 0 2 0 0 7
2020/202139 2 0 2 5 0 1 2 1 4 9 0 13
2021/202248 1 1 2 0 1 2 27 1 4 0 8 1
2022/202391 0 4 2 5 8 5 7 4 39 3 6 8
2023/20245 0 1 4 0 0 0 0 0 0 0 0 0
Totale 206